NCT03939650

Brief Summary

Single-center, unblinded, 2:1 parallel pseudo-randomized efficacy trial. In the intervention group only, resident physicians will be assisted by the automated medical history-taking device "Diaana" during their consultations in outpatient ambulatory unit of the Geneva University Hospital. In both groups, the differential diagnosis of the resident physician will be compared to the gold-standard diagnosis of the senior physician.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 7, 2019

Completed
9 months until next milestone

Study Start

First participant enrolled

January 31, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

September 23, 2021

Status Verified

October 1, 2019

Enrollment Period

Same day

First QC Date

May 3, 2019

Last Update Submit

September 17, 2021

Conditions

Keywords

differential diagnosishospital outpatient clinicsclinical applications software

Outcome Measures

Primary Outcomes (1)

  • Accuracy of the diagnosis established by the resident physician

    The resident physician will select up to 5 diagnose in an exhaustive list, from the most to the least relevant. The accuracy of the diagnosis established will be measured as following: * 100% if the gold-standard diagnosis is in position#1 into the resident diagnosis list * 80% if the gond-standard diagnosis is in position#2 * 60% in position #3 * 40% in position #4 * 20% in position #5 * 0% if the gold-standard diagnosis absent of the resident diagnosis list A higher percentage is considered as a better outcome.

    At day 0

Secondary Outcomes (3)

  • Consultation time

    At day 0

  • Patient satisfaction: Likert 1-4 scale

    At day 0

  • Differential diagnosis established by Diaana

    At day 0

Study Arms (2)

Diaana

EXPERIMENTAL

1. The patient fulfill Diaana 2. The resident physician reads the Diaana summary 3. The resident physician see the patient in consultation. He establishes his DD without having access to the complementray exams (blood tests, x-ray, ...) 4. The senior physician see the patient at the follow-up consultation. He establishes the gold-standard diagnosis highlighted by complementary exams and imagery.

Device: Diaana

Control

NO INTERVENTION

1. The resident physician see the patient in consultation. He establishes his DD without having access to the complementray exams (blood tests, x-ray, ...) 2. The senior physician see the patient at the follow-up consultation. He establishes the gold-standard diagnosis highlighted by complementary exams and imagery.

Interventions

DiaanaDEVICE

Diaana, the AMHTD used, functions as follows: on the basis of an interactive questionnaire completed by the patient before the consultation, it performs an exhaustive anamnesis focused on the problem and proposes a panel of DDs with a high sensitivity. The artificial reasoning system of "Diaana" mimics how a specialist physician would reason to establish a DD. The information transmitted is in an easy-to-use form for the physician that includes a summary of the anamnesis centered on relevant elements from the questionnaire and a list of possible diagnoses with their emergency level, potential contributing factors, and first-line management proposals.

Also known as: Automated medical history-taking device (AMHTD)
Diaana

Eligibility Criteria

Age16 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients presenting to the emergency outpatient unit of La Colline hospital (Geneva, Switzerland)
  • Patients suffering from symptoms localized to the superior or inferior member, the back, hand the chest wall.

You may not qualify if:

  • Strictly dermatologic concerns
  • Toes trauma (because the diagnosis of those conditions is generally obvious)
  • Medical condition considered as urgent
  • Inability to complete de digilatized Diaana form (sight problems, language, inability to use a tablet computer)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

La Colline Hospital Outpatient Unit

Geneva, 1206, Switzerland

Location

MeSH Terms

Conditions

Patient Participation

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: For each of the six resident physicians of the outpatients clinic, the 6 first eligible patients will be attributed to the control group (with access to "Diaana"), then the 12 next eligible patients will be attributed to the interventional group (with access to "Diaana"). There will therefore be 36 patients in the control group and 72 in the interventional group.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical doctor & principal investigator

Study Record Dates

First Submitted

May 3, 2019

First Posted

May 7, 2019

Study Start

January 31, 2020

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

September 23, 2021

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations